Tennessee Cannabiz

  Cannabis As Schedule III  Cannabis and Chronic Pain: What the Evidence Shows Note on the evidence: For decades, cannabis research in the United States was constrained by its classification as a Schedule I substance, limiting access, funding, product consistency, and long-term clinical trials. With marijuana now moved to Schedule III, many of the most rigorous studies have only just become feasible. The findings summarized below reflect the best evidence available to date — not the full scope of what future research may reveal. TL;DR Cannabis and cannabinoids show modest pain relief , strongest for neuropathic chronic pain . Major reviews (including the 2017 National Academies report) find cannabis is more effective than placebo for chronic pain, but effects are generally small. Benefits vary by product, dose, and delivery method, with inhaled and THC-containing products showing stronger effects. Adverse effects are usually mild and sh...

  Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean Schedule I vs Schedule III Under the U.S. Controlled Substances Act (CSA), drugs are classified into schedules based on their accepted medical use, potential for abuse, and risk of dependence. Two key schedules in this context are Schedule I and Schedule III: Schedule I : Drugs with no currently accepted medical use in the U.S., a high potential for abuse , and potentially severe psychological or physical dependence. Examples include heroin, LSD, and currently, marijuana (cannabis). Schedule III : Drugs with accepted medical use , moderate to low potential for physical and psychological dependence, and a lower abuse risk compared to Schedules I or II. Examples include ketamine, anabolic steroids, testosterone, and certain codeine combinations (like Tylenol with codeine). Rescheduling marijuana from Schedule I to Schedule III would formally recognize its medical benefits...

Cannabis Plea For Presidential Clemency Free the Green: A Plea for Federal Marijuana Rescheduling Tennessee has already shown us what happens when entrenched interests and moral gatekeepers get to decide the fate of cannabis. High-THCA hemp is being outlawed, alcohol profiteers are cementing control over legal hemp, and private prisons still profit from outdated laws. The result? Ordinary citizens and small businesses are punished, while special interests thrive. The Holier-Than-Thou Interference Too often, policy is driven not by science or fairness, but by people and organizations who think they know better than everyone else. Regulators, politicians, and industry lobbyists have allowed personal biases and financial incentives to dictate what Americans can grow, sell, or consume. THCA bans, complex licensing systems, and arbitrary enforcement all prove the point: when marijuana is scheduled federally as it is now, interference from outsiders rules the day. Why Rescheduling Ma...